CREBBP and Cirrhosis: Moreover, ICG-001, which blocks β-catenin’s interaction with CBP [29], inhibits fibrosis in the lungs, kidneys, and liver [30–32], and has positive results in patients with hepatitis C virus-related cirrhosis [33].